Abbott to sell Abbott Medical Optics to Johnson & Johnson for $4.325 billion

Abbott (NYSE: ABT) announced today that it will sell Abbott Medical Optics, its vision care business, to Johnson & Johnson for $4.325 billion in cash. Abbott's vision business has products in areas including cataract surgery, laser vision correction (LASIK) and corneal care products (contact solution, eye drops, etc.).
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Abbott Business and Industry Source Type: news